q&more
My watch list
my.chemie.de  
Login  

News

Viral decoys - how the Ebola virus leads the immune system astray

University Hospital Tübingen

Human cells that produce virosomes. For this, the cells were manipulated so that they pro-duce fluorescently labeled Ebola envelope protein. This is incorporated into the cell membranes and released as virosomes. These have a size of about ten thousandths of a millimeter and were visual-ized via high-resolution microscopy.

14-Feb-2019: A research team from Tübingen and Göttingen has described in the journal Cell Reports a new mechanism how the Ebola virus escapes the immune system. The virus causes infected cells to release decoys that inactivate neutralizing antibodies and prevent immune cells from releasing important messenger molecules. These findings could lead to the development of new vaccines against hemorrhagic fever viruses.

As reported by the team led by the Tübingen virologist Prof. Michael Schindler, the glycoprotein of the Ebola virus causes cells to release small vesicles bearing the Ebola virus glycoprotein on their surface. These so-called virosomes bind antibodies directed against the Ebola virus glycoprotein and could thereby interfere with control of viral infection by the antibody response. In addition, the virosomes suppress the release of cytokines and chemokines by macrophages. Macrophages are scavenger cells that release messenger molecules and thereby coordinate the immune responses against invading viruses.

Why do most patients mount an immune response against Ebola virus despite the release of virosomes? Again, the virologists have an explanation: "The immune system has developed countermeasures against virosomes," explains Schindler. "We were able to show that another cellular protein, which plays an important role in innate immune defense, can prevent the release of virosomes.”

The newly discovered properties of virosomes are of importance for basic research. In addition, they have implications for therapy and prevention. "The virosomes apparently carry functionally intact Ebola glycoprotein on their surface, but are otherwise not infectious," explains Prof. Stefan Pöhlmann, co-author of the study and head of the Infection Biology Unit at the German Primate Center in Göttingen. "This makes virosomes attractive candidates for vaccine development."

The researchers now want to investigate whether other hemorrhagic fever viruses also release virosomes and whether they can be used for the production of vaccines.

Original publication:
"Release of immunomodulatory Ebola virus glycoprotein-containing microvesicles is suppressed by tetherin in a species-specific manner"; Julia Nehls, Ramona Businger, Markus Hoffmann, Constantin Brinkmann, Birgit Fehrenbacher, Martin Schaller, Brigitte Maurer, Caroline Schönfeld, Daniela Krämer, Stephan Hailfinger, Stefan Pöhlmann, Michael Schindler; Cell Reports; 2019

q&more – the networking platform for quality excellence in lab and process

The q&more concept is to increase the visibility of recent research and innovative solutions, and support the exchange of knowledge. In the broad spectrum of subjects covered, the focus is on achieving maximum quality in highly innovative sectors. As a modern knowledge platform, q&more offers market participants one-of-a-kind networking opportunities. Cutting-edge research is presented by authors of international repute. Attractively presented in a high-quality context, and published in German and English, the original articles introduce new concepts and highlight unconventional solution strategies.

> more about q&more

q&more is supported by:



Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE